Stephen P Fitzgerald1,2,3, Nigel G Bean4,5, Henrik Falhammar6,7,8, Jono Tuke4,5. 1. Department of General Medicine and Royal Adelaide Hospital, Adelaide, South Australia. 2. Department of Endocrinology, Royal Adelaide Hospital, Adelaide, South Australia. 3. School of Medicine, University of Adelaide, Adelaide, South Australia. 4. School of Mathematical Sciences, University of Adelaide, Adelaide, South Australia. 5. ARC Centre of Excellence for Mathematical and Statistical Frontiers, University of Adelaide, Adelaide, South Australia. 6. Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Sweden. 7. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. 8. Wellbeing and Chronic Preventable Diseases Division, Menzies School of Health Research and Royal Darwin Hospital, Tiwi, Australia.
Abstract
Background: Though the functional states of other endocrine systems are not defined on the basis of levels of controlling hormones, the assessment of thyroid function is based on levels of the controlling hormone thyrotropin (TSH). We, therefore, addressed the question as to whether levels of thyroid hormones [free thyroxine (fT4), total triiodothyronine (TT3)/free triiodothyronine (fT3)], or TSH levels, within and beyond the reference ranges, provide the better guide to the range of clinical parameters associated with thyroid status. Methods: A PubMed/MEDLINE search of studies up to October 2019, examining associations of levels of thyroid hormones and TSH, taken simultaneously in the same individuals, with clinical parameters was performed. We analyzed atrial fibrillation, other cardiac parameters, osteoporosis and fracture, cancer, dementia, frailty, mortality, features of the metabolic syndrome, and pregnancy outcomes. Studies were assessed for quality by using a modified Newcastle-Ottawa score. Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed. A meta-analysis of the associations was performed to determine the relative likelihood of fT4, TT3/fT3, and TSH levels that are associated with the clinical parameters. Results: We identified 58 suitable articles and a total of 1880 associations. In general, clinical parameters were associated with thyroid hormone levels significantly more often than with TSH levels-the converse was not true for any of the clinical parameters. In the 1880 considered associations, fT4 levels were significantly associated with clinical parameters in 50% of analyses. The respective frequencies for TT3/fT3 and TSH levels were 53% and 23% (p < 0.0001 for both fT4 and TT3/fT3 vs. TSH). The fT4 and TT3/fT3 levels were comparably associated with clinical parameters (p = 0.71). More sophisticated statistical analyses, however, indicated that the associations with TT3/fT3 were not as robust as the associations with fT4. Conclusions: Thyroid hormones levels, and in particular fT4 levels, seem to have stronger associations with clinical parameters than do TSH levels. Associations of clinical parameters with TSH levels can be explained by the strong negative population correlation between thyroid hormones and TSH. Clinical and research components of thyroidology currently based on the measurement of the thyroid state by reference to TSH levels warrant reconsideration.
Background: Though the functional states of other endocrine systems are not defined on the basis of levels of controlling hormones, the assessment of thyroid function is based on levels of the controlling hormone thyrotropin (TSH). We, therefore, addressed the question as to whether levels of thyroid hormones [free thyroxine (fT4), total triiodothyronine (TT3)/free triiodothyronine (fT3)], or TSH levels, within and beyond the reference ranges, provide the better guide to the range of clinical parameters associated with thyroid status. Methods: A PubMed/MEDLINE search of studies up to October 2019, examining associations of levels of thyroid hormones and TSH, taken simultaneously in the same individuals, with clinical parameters was performed. We analyzed atrial fibrillation, other cardiac parameters, osteoporosis and fracture, cancer, dementia, frailty, mortality, features of the metabolic syndrome, and pregnancy outcomes. Studies were assessed for quality by using a modified Newcastle-Ottawa score. Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed. A meta-analysis of the associations was performed to determine the relative likelihood of fT4, TT3/fT3, and TSH levels that are associated with the clinical parameters. Results: We identified 58 suitable articles and a total of 1880 associations. In general, clinical parameters were associated with thyroid hormone levels significantly more often than with TSH levels-the converse was not true for any of the clinical parameters. In the 1880 considered associations, fT4 levels were significantly associated with clinical parameters in 50% of analyses. The respective frequencies for TT3/fT3 and TSH levels were 53% and 23% (p < 0.0001 for both fT4 and TT3/fT3 vs. TSH). The fT4 and TT3/fT3 levels were comparably associated with clinical parameters (p = 0.71). More sophisticated statistical analyses, however, indicated that the associations with TT3/fT3 were not as robust as the associations with fT4. Conclusions: Thyroid hormones levels, and in particular fT4 levels, seem to have stronger associations with clinical parameters than do TSH levels. Associations of clinical parameters with TSH levels can be explained by the strong negative population correlation between thyroid hormones and TSH. Clinical and research components of thyroidology currently based on the measurement of the thyroid state by reference to TSH levels warrant reconsideration.
Authors: Arjola Bano; Layal Chaker; Josje Schoufour; M Arfan Ikram; Maryam Kavousi; Oscar H Franco; Robin P Peeters; Francesco U S Mattace-Raso Journal: J Clin Endocrinol Metab Date: 2018-01-01 Impact factor: 5.958
Authors: Avantika C Waring; Stephanie Harrison; Howard A Fink; Mary H Samuels; Peggy M Cawthon; Joseph M Zmuda; Eric S Orwoll; Douglas C Bauer Journal: J Bone Miner Res Date: 2013-03 Impact factor: 6.741
Authors: Anders Svare; Tom I L Nilsen; Trine Bjøro; Bjørn O Asvold; Arnulf Langhammer Journal: Clin Endocrinol (Oxf) Date: 2011-06 Impact factor: 3.478
Authors: Zaldy S Tan; Alexa Beiser; Ramachandran S Vasan; Rhoda Au; Sanford Auerbach; Douglas P Kiel; Philip A Wolf; Sudha Seshadri Journal: Arch Intern Med Date: 2008-07-28
Authors: Aline S da S Correia; Michele L F Nascimento; Letícia B B de M Teixeira; Silvana O E Silva; Mário Vaisman; Patricia F S Teixeira Journal: Eur Geriatr Med Date: 2021-11-24 Impact factor: 1.710
Authors: Rudolf Hoermann; Mark J Pekker; John E M Midgley; Rolf Larisch; Johannes W Dietrich Journal: Front Endocrinol (Lausanne) Date: 2022-06-09 Impact factor: 6.055
Authors: Yi Xu; Songxia Peng; Li Qin; Dianjing Sun; Jianlin Geng; Qingqing Liu Journal: Evid Based Complement Alternat Med Date: 2022-07-06 Impact factor: 2.650
Authors: Jacqueline Jonklaas; Antonio C Bianco; Anne R Cappola; Francesco S Celi; Eric Fliers; Heike Heuer; Elizabeth A McAninch; Lars C Moeller; Birte Nygaard; Anna M Sawka; Torquil Watt; Colin M Dayan Journal: Eur Thyroid J Date: 2021-02-16
Authors: Jacqueline Jonklaas; Antonio C Bianco; Anne R Cappola; Francesco S Celi; Eric Fliers; Heike Heuer; Elizabeth A McAninch; Lars C Moeller; Birte Nygaard; Anna M Sawka; Torquil Watt; Colin M Dayan Journal: Thyroid Date: 2021-02 Impact factor: 6.568
Authors: Till Ittermann; Marcello R P Markus; Martin Bahls; Stephan B Felix; Antje Steveling; Matthias Nauck; Henry Völzke; Marcus Dörr Journal: Sci Rep Date: 2021-05-18 Impact factor: 4.379
Authors: Maria Papaleontiou; Deborah A Levine; David Reyes-Gastelum; Sarah T Hawley; Mousumi Banerjee; Megan R Haymart Journal: J Clin Endocrinol Metab Date: 2021-09-27 Impact factor: 6.134